Mesoblast receives FDA clearance for Duchenne muscular dystrophy trial Apr 10, 2026 04:10PM
Mesoblast files registration for warrant exercise shares Dec 30, 2025 04:24PM
Biotechnology: Here are Piper Sandler's Top Picks and Focus Names for 2026 Dec 21, 2025 04:00AM
Jefferies Upgrades Mesoblast Limited (MSB:AU) (MESO) to Buy Nov 25, 2025 03:40AM
Cantor Fitzgerald Reiterates Overweight Rating on Mesoblast Limited (MESO) Aug 29, 2025 06:55AM


Aug 5, 2025 02:43AM Canaccord Genuity Starts Mesoblast Limited (MSB:AU) (MESO) at Buy
Jul 18, 2025 02:25AM Jefferies Downgrades Mesoblast Limited (MSB:AU) (MESO) to Hold
May 14, 2025 11:36PM Mesoblast Limited (MSB) received seven years of orphan-drug exclusive approval from US FDA
Dec 23, 2024 03:02AM Jefferies Downgrades Mesoblast Limited (MSB:AU) (MESO) to Hold
Dec 19, 2024 07:59AM Mesoblast Limited (MESO) PT Raised to $15 at Piper Sandler as FDA Approves Ryoncil
Dec 18, 2024 05:04PM FDA Approves First Mesenchymal Stromal Cell Therapy to Treat Steroid-refractory Acute Graft-versus-host Disease
Dec 18, 2024 07:30AM Mesoblast (MESO) Added to Nasdaq Biotechnology Index
Aug 29, 2024 07:50AM Piper Sandler Reiterates Overweight Rating on Mesoblast Limited (MESO)
Aug 29, 2024 03:59AM Mesoblast (MESO) Reports FY Loss of $0.09
Aug 29, 2024 03:18AM Jefferies Upgrades Mesoblast Limited (MSB:AU) (MESO) to Buy
Jul 23, 2024 07:54AM Mesoblast Limited (MESO): FDA Accepts BLA for Ryoncil in Children With Steroid-Refractory Acute Graft-Versus-Host Disease